SCP0036
Amyloid β 13-16 human
≥95% (HPLC)
Synonyme(s) :
HHQK
Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Sélectionner une taille de conditionnement
1 MG
103.00 CHF
5 MG
355.00 CHF
Sélectionner une taille de conditionnement
Changer de vue
1 MG
103.00 CHF
5 MG
355.00 CHF
About This Item
Formule empirique (notation de Hill) :
C23H36N10O6
Poids moléculaire :
548.60
Code UNSPSC :
12352200
Nomenclature NACRES :
NA.32
Produits recommandés
![[Glu11]-Amyloid β 10-16 human ≥95% (HPLC)](/deepweb/assets/sigmaaldrich/product/images/253/004/4be4057f-fdb4-45f6-950a-d1b2774044c1/640/4be4057f-fdb4-45f6-950a-d1b2774044c1.jpg)
![[Ala28]-Amyloid β 25-35 ≥95% (HPLC)](/deepweb/assets/sigmaaldrich/product/images/306/938/dd9f7c72-cfca-4ea3-8e10-a7a2a7994639/640/dd9f7c72-cfca-4ea3-8e10-a7a2a7994639.jpg)
Essai
≥95% (HPLC)
Forme
lyophilized
Composition
Peptide Content, ≥45%
Conditions de stockage
protect from light
Température de stockage
−20°C
Amino Acid Sequence
His-His-Gln-Lys
Application
Amyloid β (Aβ) refers to peptides derived from Amyloid precursor protein that vary in length from 36-43 amino acids. Aβ(s) peptides, their peptide fragments and mutated fragments are used to study a wide range of metabolic and regulatory functions including activation of kinases, regulation of cholesterol transport, function as a transcription factor, and regulators of inflammation. Aβ(s) peptides and their peptide fragments are also used to study oxidative stress, metal binding and mechanisms of protein cross-linking in the context of diseases such as Alzheimer′s disease and neurodegeneration. HHQK is a studied as a unique target site for inhibition of amyloid fibril formation and proteoglycan binding.
Code de la classe de stockage
11 - Combustible Solids
Point d'éclair (°F)
Not applicable
Point d'éclair (°C)
Not applicable
Faites votre choix parmi les versions les plus récentes :
Certificats d'analyse (COA)
Lot/Batch Number
Vous ne trouvez pas la bonne version ?
Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
J McLaurin et al.
European journal of biochemistry, 267(21), 6353-6361 (2000-10-13)
One of the major clinical features of Alzheimer's disease is the presence of extracellular amyloid plaques that are associated with glycosaminoglycan-containing proteoglycans. It has been proposed that proteoglycans and glycosaminoglycans facilitate amyloid fibril formation and/or stabilize these aggregates. Characterization of
Toshio Ariga et al.
Journal of neuroscience research, 88(11), 2303-2315 (2010-07-14)
The extracellular accumulation of amyloid beta proteins (Abetas) in neuritic plaques is one of the hallmarks of Alzheimer's disease (AD). The binding of Abetas to extracellular membranes (ECMs) is a critical step in developing AD. Abetas bind to many biomolecules
D Giulian et al.
The Journal of biological chemistry, 273(45), 29719-29726 (1998-10-29)
The beta-amyloid peptide 1-42 (Abeta1-42), a major component of neuritic and core plaques found in Alzheimer's disease, activates microglia to kill neurons. Selective modifications of amino acids near the N terminus of Abeta showed that residues 13-16, the HHQK domain
Active Filters
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique
